Javanbakht; Hassan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Javanbakht; Hassan.The latest application filed is for "interleukin-2-fc fusion proteins and methods of use".

Company Profile

9.5.14

Javanbakht; Hassan - San Francisco CA
JAVANBAKHT; Hassan - Basel CH
Javanbakht; Hassan - New York NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
INTERLEUKIN-2-Fc FUSION PROTEINS AND METHODS OF USE App 20220125884 - Baca; Manuel ; et al.	2022-04-28
Papd5 And Papd7 Inhibitors For Treating A Hepatitis B Infection App 20220096527 - HAN; Xingchun ; et al.	2022-03-31
PAPD5 and PAPD7 inhibitors for treating a hepatitis B infection Grant 11,191,775 - Han , et al. December 7, 2	2021-12-07
Oligonucleotides For Reduction Of Pd-l1 Expression App 20210147535 - PEDERSEN; Lykke ; et al.	2021-05-20
Oligonucleotides for reduction of PD-L1 expression Grant 10,829,555 - Pedersen , et al. November 10, 2	2020-11-10
Oligonucleotides for reduction of PD-L1 expression Grant 10,745,480 - Pedersen , et al. A	2020-08-18
Oligonucleotides For Reduction Of Pd-l1 Expression App 20200247884 - Kind Code	2020-08-06
Oligonucleotides For Reduction Of Pd-l1 Expression App 20200048344 - Pedersen; Lykke ; et al.	2020-02-13
Nucleic Acid Molecules For Reduction Of Papd5 Or Papd7 Mrna For Treating Hepatitis B Infection App 20190216846 - JAVANBAKHT; Hassan ; et al.	2019-07-18
Papd5 And Papd7 Inhibitors For Treating A Hepatitis B Infection App 20190194768 - HAN; Xingchun ; et al.	2019-06-27
Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection Grant 9,949,966 - Han , et al. April 24, 2	2018-04-24
Oligonucleotides For Reduction Of Pd-l1 Expression App 20170283496 - Pedersen; Lykke ; et al.	2017-10-05
Novel Dihydroquinolizinones For The Treatment And Prophylaxis Of Hepatitis B Virus Infection App 20160296515 - Han; Xingchun ; et al.	2016-10-13
Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection Grant 9,458,153 - Han , et al. October 4, 2	2016-10-04
Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection App 20160207914 - Han; Xingchun ; et al.	2016-07-21
Method of Treating Dengue Fever App 20160168186 - Javanbakht; Hassan ; et al.	2016-06-16
Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection App 20150210682 - Han; Xingchun ; et al.	2015-07-30
Method Of Treating Dengue Fever App 20130018011 - Javanbakht; Hassan ; et al.	2013-01-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.